Related Experiment Video
Updated: Jul 17, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is pro-apoptogenic
Rachael D Baker1, John Howl, Iain D Nicholl
1Research Institute in Healthcare Science, School of Applied Sciences, University of Wolverhampton, Wolverhampton WV1 1SB, United Kingdom.
Abstract:
Targeting chemotherapeutic agents directly to sites of DNA replication and repair within cancerous cells is problematic. This study attempts to address the issue of nuclear delivery of biologically active peptides with the potential to disrupt cancer cell growth. Herein, the protein transduction domain of the HIV-1 transactivator of transcription, Tat (Tat(48-60)), is used to deliver a cytotoxic peptide mimic of the cyclin-dependent kinase inhibitor, p21(WAF1/CIP1) into the nucleus. This construct, which we designate as Tat(48-60)-P10, contains the PCNA interacting protein (PIP) box. We demonstrate the utility of Tat(48-60) for peptide delivery to the nucleus and show that Tat(48-60)-P10 induces apoptosis specific to the inclusion of the wild type PIP box containing sequence. Colocalization of Tat(48-60)-P10 with nuclear PCNA was observed by immunofluorescence analysis, supporting the hypothesis that cytotoxicity is potentially related to disruption of nuclear PCNA function. The U251 and U373 glioma cell lines exhibited particular sensitivity to the construct.
Insights
This study developed a novel nuclear delivery system using a HIV-1 protein transduction domain (Tat) to deliver a cytotoxic peptide. The Tat-peptide construct effectively induced cancer cell apoptosis by disrupting nuclear PCNA function.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Targeting chemotherapeutic agents to DNA replication and repair sites in cancer cells is challenging.
- Nuclear delivery of cytotoxic peptides requires effective transport mechanisms.
Purpose of the Study:
- To develop a method for nuclear delivery of biologically active peptides.
- To investigate the potential of a Tat-peptide construct for disrupting cancer cell growth.
Main Methods:
- Utilized the HIV-1 transactivator of transcription protein transduction domain (Tat(48-60)) for nuclear peptide delivery.
- Constructed Tat(48-60)-P10, a fusion peptide containing the p21(WAF1/CIP1) mimic and a PIP box.
- Assessed cytotoxicity and nuclear PCNA colocalization via immunofluorescence in glioma cell lines.
Main Results:
- Demonstrated successful nuclear delivery of peptides using Tat(48-60).
- Tat(48-60)-P10 induced apoptosis, dependent on the wild-type PIP box sequence.
- Observed colocalization of Tat(48-60)-P10 with nuclear PCNA, suggesting disruption of its function.
- U251 and U373 glioma cells showed significant sensitivity to the construct.
Conclusions:
- The Tat(48-60) domain is effective for nuclear delivery of cytotoxic peptides.
- Tat(48-60)-P10 exhibits cancer-specific cytotoxicity potentially through PCNA interaction disruption.
- This approach offers a promising strategy for targeted cancer therapy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Anaphase Promoting Complex
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
